| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/24/2006 | US20060188534 Dispersions for the formulation of slightly or poorly soluble agents |
| 08/24/2006 | US20060188521 Disrupting sex steroid signal to thymus: bone marrow or hematopoietic cells |
| 08/24/2006 | US20060188518 Glycoconjugate vaccines for use in immune-compromised populations |
| 08/24/2006 | US20060188516 Chlamydia trachomatis antigens |
| 08/24/2006 | US20060188484 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188483 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188477 Use of interferon alpha 5 in the treatment of viral liver diseases |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/24/2006 | DE4192786B4 Masernvirus-Rekombinanter Pockenvirus-Impfstoff Measles virus recombinant poxvirus vaccine |
| 08/24/2006 | DE102005007739A1 Tetrazinderivate mit antimykotischer Wirkung und ihre Verwendung Tetrazine derivatives with antifungal activity and their use |
| 08/24/2006 | DE102005007304A1 Triazolderivate Triazole derivatives |
| 08/24/2006 | DE102005006104A1 Aqueous based agents, useful as e.g. cosmetic disinfectant and cleaner, comprises inorganic alkali- and/or alkaline- earth salts, monovalent alcohols, cationic surfactants and optionally additives and/or auxiliary materials |
| 08/24/2006 | CA2598460A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | CA2598459A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity |
| 08/24/2006 | CA2598079A1 Adjuvant composition comprising aluminium phosphate and 3d-mpl |
| 08/24/2006 | CA2598017A1 Triazole derivatives |
| 08/24/2006 | CA2597930A1 New isothiazoloquinolones and related compounds as anti-infective agents |
| 08/24/2006 | CA2597584A1 Molecules and chimeric molecules thereof |
| 08/24/2006 | CA2595620A1 Compositions for treatment of diseases of the nail unit |
| 08/24/2006 | CA2572151A1 Oligonucleotides comprising a non-phosphate backbone linkage |
| 08/23/2006 | EP1693459A1 Chimeric type 5/type 11 or type 35 adenovirus vector for preventing infection with antihuman immunodeficiency virus |
| 08/23/2006 | EP1693448A1 Double specific antibodies substituting for functional protein |
| 08/23/2006 | EP1693381A1 Glycine-rich proteins, their coding sequences and applications |
| 08/23/2006 | EP1693373A1 Enantiomerically pure beta-D-(-)-dioxolane-nucleosides |
| 08/23/2006 | EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists |
| 08/23/2006 | EP1693070A1 Procaspase 1 activation inhibitor |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1693067A1 Pharmaceutical anti-herpetic composition, method for producing a dosage form based thereon and method for the use thereof |
| 08/23/2006 | EP1693058A1 Prevention and measures for viral infection |
| 08/23/2006 | EP1692951A1 Topical antifungal composition |
| 08/23/2006 | EP1692269A1 Production of diphtheria toxin |
| 08/23/2006 | EP1692117A1 Oxazole derivatives of tetracyclines |
| 08/23/2006 | EP1691837A2 Ip-10 antibodies and their uses |
| 08/23/2006 | EP1691831A1 In ovo vaccination of campylobacter in avian species |
| 08/23/2006 | EP1691813A2 Ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one, sterile, stable; closed system for packing the solution, process for eliminating alkaline residuals of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one crystals; pharmaceutical |
| 08/23/2006 | EP1669357A8 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[ 2,3-d,6,5-d'] dipyrimidine and 10-aza-analogue thereof |
| 08/23/2006 | EP1539133B1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 08/23/2006 | EP1507794B1 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 08/23/2006 | EP1490350B1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase |
| 08/23/2006 | EP1401836B1 Imidazo¬1,2-a|pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
| 08/23/2006 | EP1369489B1 Flavonoid compound and process for producing the same |
| 08/23/2006 | EP1337529B1 Heterocyclylalkyl piperidine derivatives, their preparation and compositions containing same |
| 08/23/2006 | EP1292612B1 Glycopeptide phosphonate derivatives |
| 08/23/2006 | EP1223929B1 Cannabimimetic indole derivatives |
| 08/23/2006 | EP1212058B1 Topical treatment for prevention of ocular infections |
| 08/23/2006 | EP1198232B1 Urea substituted imidazoquinolines |
| 08/23/2006 | EP1190079B1 Control of gene expression in eukaryotic cells |
| 08/23/2006 | EP1178824B1 Staphylococcus aureus antigen-containing whole cell vaccine |
| 08/23/2006 | EP1126837B1 Fulvic acid and its use in the treatment of various conditions |
| 08/23/2006 | EP1078927B1 Carbapenem derivatives, utilization thereof and intermediate compounds of the same |
| 08/23/2006 | EP1052963B1 Use of alkanoic acid containing compositions for treating nail fungal conditions |
| 08/23/2006 | EP1051405B1 Novel dihydroxyhexanoic acid derivatives |
| 08/23/2006 | EP1012181B1 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
| 08/23/2006 | EP0822831B2 Vaccines containing a saponin and a sterol |
| 08/23/2006 | EP0800514B1 Substituted imides as tnf inhibitors |
| 08/23/2006 | CN1823076A Silicon compounds and their use |
| 08/23/2006 | CN1822843A Process for preparing particles containing an antiviral |
| 08/23/2006 | CN1822841A Anti-coronavirus drug |
| 08/23/2006 | CN1821275A Ginseng extracting method for separating ginseng polyose and extract and use of ginseng polyose |
| 08/23/2006 | CN1821271A Antibiotic peptide and its code sequence and use |
| 08/23/2006 | CN1821250A 1H-pyranyl[3,4d][1,2,3] tri-azonyl-4-ketonic compound, synthetic method and use |
| 08/23/2006 | CN1820784A Tobacco expressed foot-and-moath disease plant gene engineering vaccine and its preparing method |
| 08/23/2006 | CN1820779A Medicinal composition for treating hepatitis B and its preparing method |
| 08/23/2006 | CN1820774A Aixinling tablet for treating AIDS |
| 08/23/2006 | CN1820760A Method for preparing kitasamycin tartrate injection |
| 08/23/2006 | CN1820749A Formula of amoxycillin sodium/ambroxo/ hydrochloride powder injection and its preparing method |
| 08/23/2006 | CN1820748A Levo-ornidazole freeze-dried powder injection |
| 08/23/2006 | CN1820744A Oseltamivir phosphate granula and its preparing method |
| 08/23/2006 | CN1820616A Biological health tea |
| 08/23/2006 | CN1271063C Di (5-formylfurfuryl) ether derivatives, preparations thereof and their uses in medicines |
| 08/23/2006 | CN1271055C Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors |
| 08/23/2006 | CN1270773C Application of chitosan for preparing helicobacter pylorus vaccine adjuvant |
| 08/23/2006 | CN1270772C Anti-hepatitis-B-virus therapeutic vaccine and its adjuvant |
| 08/23/2006 | CN1270771C Influenza vaccine sucked or sprayed through nasal cavity, preparation method |
| 08/23/2006 | CN1270769C Cinobufotalin lyophilized powder for injection and its preparation method |
| 08/23/2006 | CN1270768C Medicine for treating cold disease |
| 08/23/2006 | CN1270765C Medicinal wine or liquid for treating cold |
| 08/23/2006 | CN1270752C Antiseptic and its processing method |
| 08/23/2006 | CN1270742C Antiseptic Chinese medicine composition and its prepn process |
| 08/23/2006 | CN1270738C Artemisia apiacea pill for removing summer heat and curing cold |
| 08/23/2006 | CN1270725C Inorganic nitrite and organic acid in combination as topical antiviral composition |
| 08/23/2006 | CN1270723C Azithromycin injection and its preparation |
| 08/23/2006 | CN1270722C Use of New Zealand vitexin-1 in preparing antiviral medicine |
| 08/23/2006 | CN1270633C Antivirus bactericidal health-care flowouring powder |
| 08/23/2006 | CN1270623C Chinese medicine composition for treating heaves and hepatitis of fowl and livestock |
| 08/22/2006 | US7094900 N-Aryl-2-oxazolidinones and their derivatives |
| 08/22/2006 | US7094895 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate |
| 08/22/2006 | US7094887 UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3 |
| 08/22/2006 | US7094877 Protein for use in treatment of inflammation, nervous system, pain, arthritic and skin disorders |
| 08/22/2006 | US7094809 Topical administration of dihydroxytoluene to block viral replication |
| 08/22/2006 | US7094806 Bactericides, bacteriostats |
| 08/22/2006 | US7094802 PKB-3564 substance with neovascularization inhibitory activity |
| 08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
| 08/22/2006 | US7094780 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/22/2006 | US7094772 Phosphonate compounds |
| 08/22/2006 | US7094770 Treating hepatitus B, C and D; AIDS; antiproliferative agents |
| 08/22/2006 | US7094756 relates to the surprising finding that overexpression of ABIN prevents TNF-induced lethal hepatitis in mice |
| 08/22/2006 | US7094599 Therapeutic cells which express a membrane-bound, chimeric, proteinaceous receptor comprising an extracellular CD4 fragment to bind an HIV-infected cell without contracting the infection and an intracellular portion to destroy it |
| 08/22/2006 | US7094598 gene expression vectors comprising enhancers having sequence identity to dna sequences, that elicit immune responses against viral disease |
| 08/22/2006 | US7094412 Poxvirus containing formulations and process for preparing stable poxvirus containing compositions |